Application of dendrimers to drug delivery systems-From the viewpoint of carrier design based on nanotechnology.:Application of dendrimers to drug delivery systems—From the viewpoint of carrier design based on nanotechnology
スポンサーリンク
概要
- 論文の詳細を見る
Dendrimers are unique macromolecules with highly branched structure and globular shape. Molecular size, structure, and properties of dendrimers are highly controllable. These characteristics of dendrimers are very useful for the precise design of drug carriers and hence their application to drug delivery has been actively attempted. A brief description of dendrimers is given and present status of dendrimer-based design of drug carriers is viewed. While some of widely used dendrimers are shown to be toxic, biodegradable and biocompatible dendrimers have also been developed. Various kinds of dendrimer-drug conjugates have been prepared using polyamidoamine, polyphenylether, and polyester dendrimers and anticancer drugs such as doxorubicin, methotrexate, and 5-fluorouracil. While some of these conjugates exhibit toxicity against cancer cells, their activity is still to be improved. Dendrimers with hydrophobic core and hydrophilic shell have been designed as unimolecular micelles. These dendrimers are able to encapsulate hydrophobic drugs in their interior and release them slowly. Dendrimers with an interior of basic environment have ability to encapsulate acidic drugs, such as inethotrexate. Surface modification of dendrimers has also been attempted. Various kinds of ligands, such as sugars and folate residues, have been attached to dendrimers. These dendrimers may be useful as drug carriers with target cell specificity. In addition, surface modification of dendrimers with poly (ethylene glycol) has been tried to obtain dendrimers with biocompatible surface. Rationally and precisely designed, dendrimer-based carriers may realize an accurate delivery of drugs to the target site and lead to an enhanced efficacy of drugs.
- 日本DDS学会の論文
日本DDS学会 | 論文
- 固形腫瘍における分子標的薬の現状と課題 : 腎がんの経験から
- 前立腺がんにおけるホルモン療法
- ホルモン製剤のDDSの基礎と臨床 : 特集によせて
- SN-38内包高分子ミセルNK012日米独立 phase I 試験
- 多機能性エンベロープ型ナノ構造体による人工遺伝子デリバリーシステムの創製 : 第7回日本DDS学会永井賞受賞によせて